glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research GLP-1 Agonists in Cardiovascular Diseases:
Description
Practical Advice on Switching Between GLP-1 Receptor Agonists The recommendations discussed here are largely based on the clinical experience of the authors and are summarized in Figure 2
2024;73:767-P
What happens if I stop taking GLP-1 medication
Other studies have reported neutral associations between GLP-1RA use and IBD outcomes, with no disease worsening, but also no significant benefit to the course of IBD
GLP-1 analog use is associated with improved disease course in inflammatory bowel disease: a report from the Epi-IIRN
